Wire Stories

Fluor Awarded Engineering, Procurement and Construction Management Services Contract for Iluka’s Eneabba Rare Earths Refinery in Australia

IRVING, Texas--(BUSINESS WIRE)--Fluor Corporation (NYSE: FLR) announced today that its Mining & Metals business was…

Dr. Pest Control Company – Pest control service for flying ants entering the house after rain

HONG KONG--(BUSINESS WIRE)--Entering the rainy season is conducive to the breeding of insects. Recently, flying…

Material Shortages Impede Semiconductor Equipment Lead Time, Annual Growth Rate of Foundry Capacity to Narrow to 8% in 2023, Says TrendForce

TAIPEI, Taiwan--(BUSINESS WIRE)--#Trendforce--According to TrendForce, semiconductor equipment is once again facing the dilemma of extended…

Diane Wang Attends B20 Forum Calling for the Collaboration in Cross-Border E-Commerce and Digital Capability Building for Global Women Empowerment

BEIJING--(BUSINESS WIRE)--To encourage inclusive, resilient, and sustainable global economic growth through empowering women, the B20…

SeedBlink Collaborates With TDCX to Help Its Portfolio Companies Acquire New Customers and Build Customer Loyalty

Collaboration will help startups to accelerate growth and to improve cost efficiency BUCHAREST, Romania--(BUSINESS WIRE)--SeedBlink,…

Pacific Prime Opens Its ‘Scholarship Program 2022’ for Students in Asia Pacific

SINGAPORE--(BUSINESS WIRE)--Global health insurance brokerage Pacific Prime opens its ‘Scholarship Program 2022’, catering to high…

Fibocom and Aetina Collaborate to Bring 5G Release 16 Capabilities to AI Edge Computer Based on NVIDIA® Jetson Xavier™ NX

Integrated with Fibocom FM160-EAU module, which features 3GPP Release 16 capabilities, Aetina AN810-XNX edge AI…

Peak Performance! ZOVOO 2022 Global Online Launch will be held soon

SHENZHEN, China--(BUSINESS WIRE)--ZOVOO 2022 Global Online Product Launch will kick off at 10 PM (GMT+8)…

Trastuzumab Deruxtecan Type II Variation Application Validated by EMA for Patients with HER2 Low Metastatic Breast Cancer with HR Positive and HR Negative Disease

Application based on DESTINY-Breast04 results that showed Daiichi Sankyo and AstraZeneca’s trastuzumab deruxtecan demonstrated superior…

InnoCare Announces First Patient Dosed in Clinical Trial of Novel SHP2 Allosteric Inhibitor ICP-189 in China

BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on the treatment of cancer…